Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Vaccines breed viciousness

13.12.2001


Vaccines can drive the evolution of virulent disease.
© Photodisc


Vaccinations may increase death toll.

Inadequate vaccines can the encourage emergence of nastier bugs, placing the unprotected at risk, a new mathematical model shows. The effect could undermine future vaccination programmes.

Many vaccines save people from dying of a disease, but do not stop them carrying and transmitting it. Over a few decades this may cause more virulent strains to evolve, predict Andrew Read and his colleagues of the University of Edinburgh, UK1.



In some situations, such as in areas endemic for malaria, deadlier disease strains could kill more people than vaccination saves. "Most of the time the benefits [of vaccination] will be eroded," says Read.

Vaccines for HIV, and hepatitis B and C "give most cause for concern", says immunologist Charles Bangham, of Imperial College in London. These viruses are difficult for the body’s immune system to eradicate, leaving them time to reproduce and evolve. Tearaway strains of flu also emerge regularly and evade existing vaccines.

Infections that linger in the body are more likely to meet a second bug, explains evolutionary biologist Dieter Ebert from the University of Fribourg in Switzerland. The competition drives pathogens to evolve faster, nastier killing tactics to get the most from their host.

Don’t encourage them

Vaccines that encourage evolution include those that slow a disease-causing organism’s growth or target its harmful toxin. These types are being pursued to fight diseases such as anthrax and malaria. The possibility that these might save individuals but harm populations "has not been considered before", says Ebert, and should be a factor in public-health policy.

Most existing vaccines, such as those for smallpox, polio and measles, are very effective as they use a different strategy. They stimulate a natural immune reaction which either kills off subsequent infections or blocks pathogen reproduction and transmission altogether. Read does not advocate halting such programmes. New vaccines should similarly aim to prevent pathogens getting a toehold, says Bangham; many in the pipeline do not.

Several different vaccines are being developed to fight malaria: results of clinical trials for one that interrupts the life cycle of microorganism Plasmodium falciparum were announced last week2. ’Multivalent vaccines’ that target several different parts of a pathogen or life cycle at once are the better choice, Read suggests.

References

  1. Gandon, S., Mackinnon, M. J., Nee, S. & Read, A. F. Imperfect vaccines and the evolution of pathogen virulence. Nature, 414, 751 - 756, (2001).
  2. Bojang, K. A. et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet, 358, 1927 - 934, (2001).

HELEN PEARSON | © Nature News Service
Further information:
http://www.nature.com/nsu/011213/011213-14.html

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>